Modification of Posttetanic Count (PTC) for Monitoring Deep Neuromuscular Block II
Sponsored by Rigshospitalet, Denmark
About this trial
Last updated 16 years ago
Study ID
PTC-II
Status
Completed
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
18 to 65 Years
All Sexes
Trial Timing
Started 20 years ago
What is this trial about?
The purpose of this study is to examine the relationship between post-tetanic count (PTC) and time to first response to Train of four (TOF) stimulation during deep neuromuscular blockade induced by rocuronium.
What are the participation requirements?
Inclusion Criteria
* ASA 1-3
* General anaesthesia >1 hour
* Surgery in supine position with possibility of monitoring the neuromuscular blockade at the thumb (n.ulnaris stimulation).
* Written informed content
Exclusion Criteria
* Neuromuscular disorders, hepatic and renal dysfunction
* Medication expected to interfere with the neuromuscular blocking agent
* Allergy to any medication used during anaesthesia
* Body weight less or exceeding 20% of the ideal body weight
* Pregnancy or breastfeeding